10-K Decoder · All companies

Ginkgo Bioworks Holdings, Inc.

DNA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$170M$227M−25.1%
Operating income−$315M−$560M+43.7%
Net income−$313M−$547M+42.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$27.7M$29.4M−5.8%
Operating income−$43.6M−$82.3M+47.0%
Net income−$41.0M−$80.8M+49.3%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Ginkgo Bioworks's revenue in FY2025?
$170M in FY2025 (Fiscal year ended Dec 31, 2025), −25.1% vs $227M a year earlier, per its 10-K filed Feb 2026.
Was Ginkgo Bioworks profitable in FY2025?
No: net income was −$313M and operating income −$315M in FY2025.
What was Ginkgo Bioworks's revenue in Q3 2026?
$27.7M (−5.8% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.